Azacyclic compounds
First Claim
Patent Images
1. A compound of formula (I) whereinZ is
- wherein R is a lower alkyl group, wherein said lower alkyl group is a methyl; and
n is 1;
X1 is methylene, vinylene, or an NH or N(lower alkyl) group; and
X2 is methylene;
or, when X1 is methylene or vinylene, X2 is methylene or a bond;
or when X1 is methylene, X2 is O, S, NH, or N(lower alkyl) or a bond;
Y1 is methylene and Y2 is methylene, vinylene, ethylene, propylene, or a bond;
or Y1 is a bond and Y2 is vinylene;
or Y1 is ethylene and Y2 is O, S, NH, or N(lower alkyl);
Ar1 and Ar2 independently are unsubstituted or substituted aryl or heteroaryl groups, provided that Ar1 and Ar2 are not simultaneously unsubstituted phenyl; and
W is oxygen;
or a pharmaceutically acceptable salt or prodrug thereof.
2 Assignments
0 Petitions
Accused Products
Abstract
Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is adminstered to a patient in need of such treatment.
-
Citations
5 Claims
-
1. A compound of formula (I)
wherein Z is - wherein R is a lower alkyl group, wherein said lower alkyl group is a methyl; and
n is 1;
X1 is methylene, vinylene, or an NH or N(lower alkyl) group; and
X2 is methylene;
or, when X1 is methylene or vinylene, X2 is methylene or a bond;
or when X1 is methylene, X2 is O, S, NH, or N(lower alkyl) or a bond;
Y1 is methylene and Y2 is methylene, vinylene, ethylene, propylene, or a bond;
orY1 is a bond and Y2 is vinylene;
orY1 is ethylene and Y2 is O, S, NH, or N(lower alkyl);
Ar1 and Ar2 independently are unsubstituted or substituted aryl or heteroaryl groups, provided that Ar1 and Ar2 are not simultaneously unsubstituted phenyl; and
W is oxygen;
ora pharmaceutically acceptable salt or prodrug thereof.
- wherein R is a lower alkyl group, wherein said lower alkyl group is a methyl; and
-
2. A compound of formula (I)
wherein Z is - wherein R is a hydrogen, a cyclic or straight-chained or branched acyclic organyl group, a lower hydroxyalkyl group, a lower aminoalkyl group, or an aralkyl or heteroaralkyl group; and
n is 1;
X1 is an NH, and X2 is methylene;
Y1 is methylene and Y2 is methylene, vinylene, ethylene, propylene, or a bond;
orY1 is a bond and Y2 is vinylene;
orY1 is ethylene and Y2 is O, S, NH, or N(lower alkyl);
Ar1 and Ar2 independently are unsubstituted or substituted aryl or heteroaryl groups, provided that Ar1 and Ar2 are not simultaneously unsubstituted phenyl; and
W is oxygen;
ora pharmaceutically acceptable salt or prodrug thereof.
- wherein R is a hydrogen, a cyclic or straight-chained or branched acyclic organyl group, a lower hydroxyalkyl group, a lower aminoalkyl group, or an aralkyl or heteroaralkyl group; and
-
3. A compound of formula (I)
wherein Z is - wherein R is a hydrogen, a cyclic or straight-chained or branched acyclic organyl group, a lower hydroxyalkyl group, a lower aminoalkyl group, or an aralkyl or heteroaralkyl group; and
n is 1;
X1 is methylene, vinylene, or an NH or N(lower alkyl) group; and
X2 is methylene, or, when X1 is methylene or vinylene, X2 is methylene or a bond;
or when X1 is methylene, X2 is O, S, NH, or N(lower alkyl) or a bond;
Y1 is methylene and Y2 is a bond;
Ar1 and Ar2 independently are unsubstituted or substituted aryl or heteroaryl groups, provided that Ar1 and Ar2 are not simultaneously unsubstituted phenyl; and
W is oxygen;
ora pharmaceutically acceptable salt or prodrug thereof.
- wherein R is a hydrogen, a cyclic or straight-chained or branched acyclic organyl group, a lower hydroxyalkyl group, a lower aminoalkyl group, or an aralkyl or heteroaralkyl group; and
-
4. A compound of formula (I)
wherein Z is - wherein R is a hydrogen, a cyclic or straight-chained or branched acyclic organyl group, a lower hydroxyalkyl group, a lower aminoalkyl group, or an aralkyl or heteroaralkyl group; and
n is 1;
X1 is methylene, vinylene, or an NH or N(lower alkyl) group; and
X2 is methylene, or, when X1 is methylene or vinylene, X2 is methylene or a bond;
or when X1 is methylene, X2 is O, S, NH, or N(lower alkyl) or a bond;
Y1 is methylene and Y2 is methylene, vinylene, ethylene, propylene, or a bond;
orY1 is a bond and Y2 is vinylene;
orY1 is ethylene and Y2 is O, S, NH, or N(lower alkyl);
Ar1 is a 4-haloaryl, wherein said aryl is phenyl and said halo is a fluoro;
Ar2 is a 4-substituted aryl, wherein said aryl is phenyl, and said phenyl is substituted with a lower alkoxy group, wherein the alkyl group of said lower alkoxy group is an isobutyl; and
W is oxygen;
ora pharmaceutically acceptable salt or prodrug thereof.
- wherein R is a hydrogen, a cyclic or straight-chained or branched acyclic organyl group, a lower hydroxyalkyl group, a lower aminoalkyl group, or an aralkyl or heteroaralkyl group; and
-
5. A tartrate salt of a compound of formula (I)
wherein Z is - wherein R is a hydrogen, a cyclic or straight-chained or branched acyclic organyl group, a lower hydroxyalkyl group, a lower aminoalkyl group, or an aralkyl or heteroaralkyl group; and
n is 1;
X1 is methylene, vinylene, or an NH or N(lower alkyl) group; and
X2 is methylene, or, when X1 is methylene or vinylene, X2 is methylene or a bond;
or when X1 is methylene, X2 is O, S, NH, or N(lower alkyl) or a bond;
Y1 is methylene and Y2 is methylene, vinylene, ethylene, propylene, or a bond;
orY1 is a bond and Y2 is vinylene;
orY1 is ethylene and Y2 is O, S, NH, or N(lower alkyl);
Ar1 and Ar2 independently are unsubstituted or substituted aryl or heteroaryl groups, provided that Ar1 and Ar2 are not simultaneously unsubstituted phenyl; and
W is oxygen.
- wherein R is a hydrogen, a cyclic or straight-chained or branched acyclic organyl group, a lower hydroxyalkyl group, a lower aminoalkyl group, or an aralkyl or heteroaralkyl group; and
Specification